Gene Modified T Cell Therapies for Hematological Malignancies

被引：5
|
作者：
Abramowski-Mock, Ulrike [1 ]
Delhove, Juliette M. [1 ]
Qasim, Waseem [1 ]
机构：
[1] UCL, Mol & Cellular Immunol Unit, UCL Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 31卷 / 05期
基金：
“创新英国”项目;
关键词：
Gene therapy; Gene editing; Adoptive immunotherapy; T cell receptor; Chimeric antigen receptor; Lentiviral vectors; Leukemia; Lymphoma; CHIMERIC-ANTIGEN-RECEPTOR; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER NUCLEASES; B-CELL; CANCER-IMMUNOTHERAPY; ADOPTIVE IMMUNOTHERAPY; IMMUNE CHECKPOINTS; MULTIPLE-MYELOMA; CLINICAL-TRIAL; LYMPHOCYTES;
D O I：
10.1016/j.hoc.2017.06.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This article focuses on clinical applications of T cells transduced to express recombinant T-cell receptor and chimeric antigen receptor constructs directed toward hematological malignancies, and considers newer strategies incorporating gene-editing technologies to address graft-versus-host disease and host-mediated rejection. Recent data from clinical trials are reviewed, and an overview is provided of current and emerging manufacturing processes; consideration is also given to new developments in the pipeline.
引用
收藏
页码：913 / +
页数：15
相关论文
共 50 条
  • [31] Gene and virotherapy for hematological malignancies
    Domingo-Musibay, Evidio
    Yamamoto, Masato
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (01) : 29 - 41
  • [32] Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies
    Arunachalam, Arun K.
    Gregoire, Celine
    de Oliveira, Beatriz Coutinho
    Melenhorst, Jan Joseph
    BLOOD REVIEWS, 2024, 68
  • [33] T Cell Redirecting Therapies for Cancer Treatment
    Sasu, Barbra
    Chaparro-Riggers, Javier
    CURRENT CANCER DRUG TARGETS, 2016, 16 (01) : 22 - 33
  • [34] Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies
    Mehravar, Maryam
    Roshandel, Elham
    Salimi, Maryam
    Chegeni, Rouzbeh
    Gholizadeh, Majid
    Mohammadi, Mohammad Hossein
    Hajifathali, Abbas
    IMMUNOLOGY LETTERS, 2020, 226 : 71 - 82
  • [35] CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges
    Narkhede, Mayur
    Mehta, Amitkumar
    Ansell, Stephen M.
    Goyal, Gaurav
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [36] Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies
    Abbasi, Samane
    Totmaj, Milad Asghari
    Abbasi, Masoumeh
    Hajazimian, Saba
    Goleij, Pouya
    Behroozi, Javad
    Shademan, Behrouz
    Isazadeh, Alireza
    Baradaran, Behzad
    CANCER MEDICINE, 2023, 12 (07): : 7844 - 7858
  • [37] Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies
    Lin, Wen-Ying
    Wang, Hsin-Hui
    Chen, Yi-Wei
    Lin, Chun-Fu
    Fan, Hueng-Chuen
    Lee, Yi-Yen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 21
  • [38] Redirecting T cells to hematological malignancies with bispecific antibodies
    Velasquez, Mireya Paulina
    Bonifant, Challice L.
    Gottschalk, Stephen
    BLOOD, 2018, 131 (01) : 30 - 38
  • [39] Lysosome targeted therapies in hematological malignancies
    Manivannan, Madhumita S.
    Peters, Anthea
    Gibson, Spencer B.
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [40] Advances in immune therapies in hematological malignancies
    Mazzarella, Luca
    Enblad, Gunilla
    Olweus, Johanna
    Malmberg, Karl-Johan
    Jerkeman, Mats
    JOURNAL OF INTERNAL MEDICINE, 2022, 292 (02) : 205 - 220
12345